Proteomics Market: Growth, Size, Share, and Trends

Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) & Region - Global Forecast to 2029

Report Code: BT 2341 Sep, 2024, by marketsandmarkets.com

Market Growth Outlook Summary

The global proteomics market growth forecasted to transform from USD 33.6 billion in 2024 to USD 60.5 billion by 2029, driven by a CAGR of 12.4%. The major factors driving growth in the proteomics market are the growing demand for personalized medicines for clinical practices, rising applications in drug discovery and development, growing government & private funding, clinical trial and translational research expansion, biologics and biosimilars development, increasing focus on monoclonal antibodies and therapeutic proteins, and improved techniques in protein quantification. Additionally, advancements in single-cell proteomics and bioinformatics are further driving the growth of the proteomics market.

Proteomics Market Trends

Proteomics Market

To know about the assumptions considered for the study, Request for Free Sample Report

Attractive Opportunities in the Proteomics Market

Proteomics Market

Proteomics Market Dynamics

Driver: Rising demand for personalized medicine

Proteomics plays an important role in personalized medicine by providing insights at the molecular level. The results make it possible to implement targeted therapies to support individualized medicine through biomarker discovery, identification of drug targets, and follow-up of therapy responses. During the last decade, there has been an increased usage of personalized medicines. In 2021, the FDA's Centre for Drug Evaluation and Research approved 50 novel molecular entities, all but 2 of which were therapeutic goods. Similarly, in 2022, the US FDA approved around 37 NMEs.

Restraints: High cost of instruments

One of the major factors limiting the growth of the proteomics market is the requirement of high investments initially. These are highly sophisticated, fully automated systems, with a relatively high capital expenditure towards procurement, installation, and integration into existing lines of production. This can be very expensive, owing to which raising the stake is quite hard for small and medium-sized enterprises, which form a large part of the manufacturing industry. Although these companies play an important role in product quality and regulatory compliance, steep costs may deter them from adopting essential instruments. Mass spectrometers and chromatography systems are examples of advanced proteomic tools, but they come at a cost. For example, state-of-the-art mass spectrometers run into several hundred thousand dollars—thus posing a considerable expense for research institutions and biotech companies. For example, only reagents for running a single mass spectrometry analysis can be in the range of USD 100–300. The cost in terms of specialists can also run into thousands of dollars a year for institutions if hiring and training are to be done. For small research labs or academic institutions, such expenses are unaffordable.

Opportunity: Advancements in bioinformatics

Advancements in bioinformatics are a key factor driving growth in the proteomics market. Some major technological advancements are software tools for data analysis and interpretation, such as MaxQuant and Proteome Discoverer, that enhance accuracy and speed in identifying and quantifying proteins from mass spectrometry data. Such tools help in the fast, parallel analysis of comprehensive datasets and in predicting the subtle interactions of proteomes and pathways. Technologies in bioinformatics, like computational proteomics and next-generation sequencing technologies, are revolutionizing biological and clinical research. Mass spectrometry allows for high-throughput and exact protein analysis, and NGS allows for fast, inexpensive sequencing of samples to reveal deviations, providing complete transcriptome profiles and identifying microbes. Among the NGS technologies, metagenomic NGS is best suited to detect pathogenic organisms in extremely complex samples. Furthermore, machine learning and artificial intelligence are currently changing the bioinformatics applications in proteomics. For prototyping exact precision in predicting protein structures, functions, and interactions, state-of-the-art algorithms harnessed from artificial intelligence, such as AlphaFold by DeepMind, are increasingly being used. They also empower fast turnaround for designing drug targets and therapeutic molecules.

Challenge: Lack of data management/handling in proteomics research

Although there is a huge volume of proteomics data that is available, the challenge in this market lies in the access and efficient utilization of the same. Poor data management can have a deleterious effect on the outcome of research and may actually turn out to be a growth inhibitor for the market. Recent studies have pointed out that owing to the inefficient handling of data, the use of proteomics data in major applications such as biomarker discovery and drug development has been restricted. For example, researchers in a major biotech company were slowed down while trying to analyze high-throughput proteomics data in the identification of potential therapeutic targets. Such delays slow not only the progress in research but also lengthen the time it takes to translate such discoveries into actionable results, which prolongs the product development cycle. Moreover, the lack of standardization of data formats and lack of interoperability between proteomics platforms make the integration of data from different research initiatives or even institutions very difficult. Besides, high-throughput experiments generate proteomics data that require specialized expertise in processing and analysis. Researchers often invest a huge amount of time in the preprocessing and analysis of proteomics data in order to extract meaningful information. The absence of separation of sample numbers in proteomics repositories makes it extremely hard to formulate the necessary research queries.

Ecosystem Analysis of Proteomics Market

Proteomics Market Ecosystem

The spectroscopy segment dominated the proteomics industry in 2023.

The proteomics market is further segmented on the basis of instrumentation technology into spectroscopy, chromatography, mass spectrometry, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. The spectroscopy segment dominated the global proteomics market in 2023 and is likely to continue to do so throughout the forecast period. The growing adoption of spectroscopy techniques in proteomics research is a key factor driving market growth. This is due to their ability to provide valuable insights into protein structure, dynamics, interactions, and functions, among other critical aspects.

The immunoassay reagents segment of the proteomics industry is poised to exhibit substantial growth at a significant CAGR throughout the forecast period.

The proteomics market is further categorized by reagents into protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, protein fractionation reagents, and other reagents. The wide availability of various reagents and the growing demand for reliable, specific, and rapid disease detection at early stages are likely to drive the market growth of immunoassay reagents.

North America dominated the global proteomics industry in 2023.

Based on region, the proteomics market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global proteomics market in 2023 and is likely to dominate throughout the forecast period. The presence of many pharmaceutical companies and the rising demand for precision medicines are likely to boost the market in the region. Additionally, the rising research funding further drives the growth of the proteomics market in North America.

Proteomics Market by Region

Source: Expert Interviews, Secondary Research, Whitepapers, Journals, Magazines, and MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

The key players in the proteomics market include Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Waters Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker Corporation (US), Revvity (US), Shimadzu Corporation (Japan), Illumina Inc. (US), Promega Corporation (US), Eurofins (Luxembourg), QIAGEN (Netherlands), Charles River Laboratories (US), and Protagene (Germany), among others.

Scope of the Proteomics Industry

Report Metric

Details

Market Revenue Size in 2024

$33.6 billion

Projected Revenue Size by 2029

$60.5 billion

Industry Growth Rate

Poised to Grow at a CAGR of 12.4%

Market Driver

Rising demand for personalized medicine

Market Opportunity

Advancements in bioinformatics

This report categorizes the proteomics market to forecast revenue and analyze trends in each of the following submarkets:

By Instrumentation Technology
  • Spectroscopy
    • Mass Spectrometry
    • NMR Spectroscopy
    • CD Spectroscopy
  • Chromatography
    • HPLC Chromatography
    • Ion Chromatography
    • Affinity Chromatography
    • Superficial Chromatography
  • Chromatography
  • Electrophoresis
    • Gel Electrophoresis
    • Capillary Electrophoresis
  • Protein Microarrays
    • Biochips
      • Lab on chips
      • Protein Chips
    • Microarray Instruments
      • Integrated Systems
      • Microarray Scanners
      • Arrayers
  • X Ray Crystallography
  • Surface Plasmon Resonance
  • Protein Fractionation
  • Other Technologies
By Reagent
  • Immunoassay Reagents
  • Spectroscopy Reagents
  • Chromatography Reagents
  • Protein Microarray Reagents
  • X Ray Crystallography Reagents
  • Electrophoresis Reagents
  • Protein Fractionation Reagents
  • Other Reagents
By Service
  • Core Proteomics Services
  • Bioinformatics Services
By Software
  • Bioinformatics Tools
  • Bioinformatics Databases
By Applications
  • Clinical Diagnostics
  • Drug Discovery & Development
  • Other Applications
By End User
  • Hospitals
  • Clinical Laboratories
  • Biopharmaceutical Companies
  • Academic & Research Institutes
  • Other End Users
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East
    • GCC Countries
      • Saudi Arabia
      • UAE
      • Rest of GCC
    • Rest of Middle East
  • Africa

Recent Developments of Proteomics Industry

  • In March 2024, Thermo Fisher Scientific Inc. (US) introduced the Thermo Scientific Stellar mass spectrometer (MS), a mass spectrometer that combines fast throughput and high sensitivity. This allows researchers to advance their translational omics research and make breakthrough discoveries more efficiently.
  • In October 2023, Thermo Fisher Scientific Inc (US) acquired Olink Holdings (Sweden) with an aim to enhance Thermo Fisher’s capabilities in the high-growth proteomics market.
  • In June 2024, Agilent Technologies, Inc. (US) launched two new products, the Agilent 7010D Triple Quadrupole GC/MS System and the Agilent ExD Cell available for the 6545XT AdvanceBio LC/Q-TOF, at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics to advance gas chromatography-mass spectrometry (GC/MS) and LC/Q-TOF technology.
  • In June 2024, Danaher Corporation (US) and Mass Analytica (Spain) collaborated to reveal artificial intelligence quantitation (AI quant) software, which offers high-resolution MS/MS analysis with an intelligent fragment selection algorithm.
  • In February 2023, Waters Corporation (US) acquired Wyatt Technology (US), which enhanced the portfolio of separation and detection and provided customers with an unmatched set of analytical solutions across a wide range of applications.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY 
    1.2 MARKET DEFINITION 
    1.3 MARKET SCOPE 
           1.3.1  MARKETS COVERED
           1.3.2  INCLUSIONS & EXCLUSIONS
           1.3.3  YEARS CONSIDERED FOR THE STUDY
    1.5 UNITS CONSIDERED 
           1.3.1  VALUE/CURRENCY UNIT
           1.3.2  VOLUME UNIT
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH DATA 
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
                    2.2.1.1 INSIGHTS FROM PRIMARY EXPERTS
           2.2.2 TOP-DOWN APPROACH
    2.3 LIMITATIONS 
    2.4 GROWTH RATE ASSUMPTIONS 
    2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 
    2.6 STUDY ASSUMPTIONS 
    2.7 RISK ANALYSIS 
 
3 EXECUTIVE SUMMARY 
 
4 PREMIUM INSIGHTS 
 
5 MARKET OVERVIEW 
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
           5.2.2 RESTRAINTS
           5.2.3 OPPORTUNITIES
           5.2.4 CHALLENGES
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS  
    5.4 PRICING ANALYSIS 
           5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
           5.4.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
    5.5 VALUE CHAIN ANALYSIS 
    5.6 ECOSYSTEM ANALYSIS 
    5.7 TECHNOLOGY ANALYSIS 
           5.7.1 KEY TECHNOLOGIES
                    5.7.1.1 MASS SPECTROMETRY
                               5.7.1.1.1 INTACT/TOP DOWN PROTEIN ANALYSIS
                    5.7.1.2 CHROMATOGRAPHY
                    5.7.1.3 BIOINFORMATICS TOOLS
                    5.7.1.4 PROTEIN MICROARRAYS
           5.7.2 COMPLEMENTARY TECHNOLOGIES
                    5.7.2.1 GENOMICS
                    5.7.2.2 TRANSCRIPTOMICS
                    5.7.2.3 METABOLOMICS
           5.7.3 ADJCENT TECHNOLOGY
                    5.7.3.1 SINGLE-CELL PROTEOMICS
    5.8 IMPACT OF GENERATIVE-AI ON PROTEOMICS MARKET 
    5.9 PATENT ANALYSIS  
    5.1 TRADE DATA ANALYSIS 
           5.10.1 IMPORT SCENERIO
           5.10.2 EXPORT SCENERIO
    5.11 KEY CONFERENCES & EVENTS 2024-2025 
    5.12 REGULATORY LANDSCAPE 
           5.12.1 REGULATORY SCENERIO
           5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS 
    5.13 PORTER’S FIVE FORCES’ ANALYSIS 
           5.13.1 THREAT OF NEW ENTRANTS
           5.13.2 THREAT OF SUBSTITUTE
           5.13.3 BARGAINING POWER OF SUPPLIERS
           5.13.4 BARGAINING POWER OF BUYERS
           5.13.5 INTENSTITY OF COMPETITION RIVALRY
    5.14 INVESTMENT AND FUNDING SCENARIO  
    5.15 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
           5.14.2 BUYING CRITERIA
 
6 PROTEOMICS INSTRUMENTATION MARKET, BY TECHNOLOGY 
    6.1 INTRODUCTION 
    6.2 SPECTROSCOPY 
           6.2.1 MASS SPECTROMETRY
           6.2.2 NMR SPECTROSCOPY
           6.2.3 CD SPECTROSCOPY
    6.3 CHROMATOGRAPHY 
           6.3.1 HPLC
           6.3.2 ION CHROMATOGRAPHY
           6.3.3 AFFINITY CHROMATOGRAPHY
           6.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY
    6.4 ELECTROPHORESIS 
           6.4.1 GEL ELECTROPHORESIS
           6.4.2 CAPILLARY ELECTROPHORESIS
    6.5 PROTEIN MICROARRAYS 
           6.5.1 BIOCHIPS
                    6.5.1.1 Lab-on-chips
                    6.3.1.2 Protein Chips
           6.5.2 MICROARRAY INSTRUMENTS
                    6.5.2.1 Integrated Systems
                    6.5.2.2 Microarray Scanners
                    6.5.2.3 Arrayers
    6.6 X-RAY CRYSTALLOGRAPHY 
    6.7 SURFACE PLASMON RESONANCE 
    6.8 PROTEIN FRACTIONATION 
    6.9 OTHER TECHNOLOGIES 
 
Note1: Tentative segmentation, subject to minor revision as research progresses. 
Note2: Other Technologies segment includes blotting, ELISA, and Edman sequencing, etc. 
 
7 PROTEOMICS REAGENTS MARKET, BY TYPE 
    7.1 INTRODUCTION 
    7.2 IMMUNOASSAY REAGENTS 
    7.3 SPECTROSCOPY REAGENTS 
    7.4 CHROMATOGRAPHY REAGENTS 
    7.5 PROTEIN MICROARRAY REAGENTS 
    7.6 X-RAY CRYSTALLOGRAPHY REAGENTS 
    7.7 ELECTROPHORESIS REAGENTS 
    7.8 PROTEIN FRACTIONATION REAGENTS 
    7.9 OTHER REAGENTS 
 
Note 3: Tentative segmentation, subject to minor revision as research progresses. 
Note 4: Other reagents segment includes reagents for Edman sequencing, enzymes, and cross-linking agents. 
 
8 PROTEOMICS SERVICES MARKET, BY TYPE  
    8.1 INTRODUCTION 
    8.2 CORE PROTEOMICS SERVICES 
           8.2.1 PROTEIN IDENTIFICATION SERVICES
           8.2.2 PROTEIN CHARACTERIZATION SERVICES 
           8.2.3 QUANTITATIVE PROTEOMICS SERVICES
           8.2.4 PROTEIN PURIFICATION SERVICES
           8.2.5 PROTEIN SEPARATION SERVICES
           8.2.6 PROTEIN SEQUENCING SERVICES
           8.2.7 CUSTOM ASSAY SERVICES
           8.2.8 BIOINFORMATICS SERVICES
 
9 PROTEOMICS SOFTWARE MARKET, BY TYPE 
    9.2 BIOINFORMATICS TOOLS 
    9.3 BIOINFORMATICS DATABASES 
 
10 PROTEOMICS MARKET, BY APPLICATION 
     10.1 INTRODUCTION 
     10.1 CLINICAL DIAGNOSTICS 
             10.2.1 CANCER
             10.2.2 INFECTIOUS DISEASES
             10.2.3 DIABETES
             10.2.4 NEUROLOGICAL DISORDERS
             10.2.5 AUTOIMMUNE DISEASES
             10.2.6 CARDIOVASCULAR DISEASES
             10.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS
 
Note 5: Other clinical diagnostic applications segment includes dermatology, blood disorders, digestive diseases, respiratory diseases, postmenopausal osteoporosis, nephrology, and rare diseases. 
     10.3 DRUG DISCOVERY & DEVELOPMENT 
             10.3.1 TARGET DISCOVERY
             10.3.2 LEAD IDENTIFICATION
             10.3.3 LEAD OPTIMIZATION
             10.3.4 PRECLINICAL STUDIES
     10.4 OTHER APPLICATIONS 
 
Note 6: Other applications segment includes protein mining (identification of proteins), protein-expression profile (identification of proteins in a state of the organism), and protein-network mapping (protein interactions in living systems and mapping of protein modifications). 
 
11 PROTEOMICS MARKET, BY END USER 
     11.1 INTRODUCTION 
     11.2 HOSPITALS 
     11.3 CLINICAL LABORATORIES 
     11.4 BIPHARMACEUTICAL COMPANIES 
     11.5 ACADEMIC & RESEARCH INSTITUTES 
     11.6 OTHER END USERS 
 
Note 7: Other end users segment includes CROs, forensic laboratories, CMOs, and CDMOs. 
 
12 PROTEOMICS MARKET, BY REGION 
     12.1 INTRODUCTION 
     12.2 NORTH AMERICA 
             12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
             12.2.2 US
             12.2.3 CANADA
     12.3 EUROPE 
             12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
             12.3.2 GERMANY
             12.3.3 UK
             12.3.4 FRANCE
             12.3.5 ITALY
             12.3.6 SWITZERLAND
             12.3.7 SPAIN
             12.3.8 REST OF EUROPE
     12.4 ASIA PACIFIC 
             12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
             12.4.2 CHINA
             12.4.3 JAPAN
             12.4.4 INDIA
             12.4.5  AUSTRALIA
             12.4.6  SOUTH KOREA
             12.4.7 REST OF ASIA PACIFIC 
     12.5 LATIN AMERICA 
             12.5.1  MACROECONOMIC OUTLOOK FOR LATIN AMERICA
             12.5.2  BRAZIL
             12.5.3  MEXICO
             12.5.4  REST OF LATIN AMERICA
     12.6  
             12.5.1  MACROECONOMIC OUTLOOK FOR MIDDLE EAST
             12.6.2 GCC COUNTRIES
                        12.6.2.1 SAUDI ARABIA (KSA)
                        12.6.2.2 UNITED ARAB EMIRATES (UAE)
                        12.6.2.3 REST OF  GCC COUNTRIES
             12.6.3 REST OF MIDDLE EAST
     12.7  
             12.7.1  MACROECONOMIC OUTLOOK FOR AFRICA
 
Note 8: Rest of Europe includes Russia, Switzerland, Portugal, Poland, Netherlands, Finland, Belgium, Austria, Hungary, Iceland, Ireland, Norway, and Luxembourg, among others 
Note 9: Rest of Asia Pacific Includes Bangladesh, Bhutan, Nepal, Sri Lanka, Philippines, Singapore, Vietnam, Thailand, Taiwan, Cambodia, and Indonesia among others 
Note 10: Rest of Latin America Includes Colombia, Ecuador, Peru, Uruguay, Cuba and Chile 
Note 11: Rest of GCC includes Bahrain, Kuwait, Qatar and Oman 
Note 13: Rest of Middle East Includes Iran, Iraq, Israel, Jordan, Qatar, Yemen, and other countries. 
 
13 COMPETITIVE LANDSCAPE 
     13.1 INTRODUCTION  
     13.2 KEY PLAYER STRATERGIES/RIGHT TO WIN 
     13.3 REVENUE ANALYSIS, 2021-2023 
     13.4 MARKET SHARE ANALYSIS, 2023 
     13.5 BRAND/PRODUCT COMPARATIVE ANALYSIS 
             13.5.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY TECHNOLOGY
     13.6 COMPANY EVALUATION MATRIX:KEY PLAYERS, 2023 
             13.6.1 STARS
             13.6.2 EMERGING LEADERS
             13.6.3 PERVASIVE PLAYERS
             13.6.4  PARTICIPANTS
             13.6.5 COMPANY FOOTPRINT:KEY PLAYERS, 2023
                        13.6.5.1 COMPANY FOOTPRINT
                        13.6.5.2 REGION FOOTPRINT
                        13.6.5.3 INSTRUMENTATION TECHNOLOGY FOOTPRINT
                        13.6.5.4 REAGENT FOOTPRINT
                        13.6.5.4 SERVICE FOOTPRINT
                        13.6.5.5 SOFTWARE FOOTPRINT
     13.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             13.7.1 PROGRESSIVE COMPANIES
             13.7.2 RESPONSIVE COMPANIES
             13.7.3 DYNAMIC COMPANIES
             13.7.4 STARTING BLOCKS
             13.7.5 COMPETITIVE  BENCHMARKING: STARTUPS/SMES, 2023
                        13.7.5.1 PROTEOMICS MARKET: KEY STARTUPS/SMES
                        13.7.5.2 PROTEOMICS MARKET: COMPETITIVE  BENCHMARKING OF KEY STARTUPS/SMES
     13.8 VALUATION AND FINANCIAL METRICS OF KEY PROTEOMICS MARKET PLAYERS 
     13.9 COMPETITIVE SCENARIO AND TRENDS 
             13.9.1 PRODUCT LAUNCHES & APPROVALS
             13.9.2 DEALS
             13.9.3 OTHER DEVELOPMENTS
 
14 COMPANY PROFILES 
(Business Overview, Products Offered, Recent Developments, Mnm View)*
     14.1 KEY PLAYERS 
             14.1.1 THERMO FISHER SCIENTIFIC INC.
             14.1.2 AGILENT TECHNOLOGIES, INC.
             14.1.3 MERCK KGAA
             14.1.4 DANAHER
             14.1.5 WATERS CORPORATION
             14.1.6 BIO-RAD LABORATORIES, INC.
             14.1.7 BRUKER CORPORATION
             14.1.8 REVITTY
             14.1.9 SHIMADZU CORPORATION
             14.1.10 ILLUMINA, INC.
             14.1.11 PROMEGA CORPORATION
             14.1.12 EUROFINS SCIENTIFIC
             14.1.13 QIAGEN 
             14.1.14 CHARLES RIVER LABORATORIES
             14.1.15 PROTAGENE 
     13.2 OTHER PLAYERS 
             13.2.1 CREATIVE PROTEOMICS
             13.2.2 HORIBA 
             13.2.3 SENGENICS CORPORATION LLC.
             13.2.4 LABVANTAGE – BIOMAX GMBH
             13.2.5 CELL SIGNALING TECHNOLOGY, INC.
             13.2.6 FIOS GENOMICS
             13.2.7 AZENTA LIFE SCIENCES
             13.2.8 MEDGENOME 
             13.2.9 BIOGNOSYS AG
             13.2.10 MACROGEN INC. 
 
*Business overview, products offered, recent developments, SWOT analysis, MNM view might not be captured in the case of unlisted companies.
Note 13: Tentative list of companies, subject to minor revision as research progresses.  
 
14 APPENDIX 
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 AVAILABLE CUSTOMIZATIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the proteomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and other approaches were employed to estimate the complete market size (proteomics market size). After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the proteomics market. The secondary sources referred to for this research study include publications from government and private sources such as the Indian Pharmaceutical Association (IPA), the Pharmaceutical Research and Manufacturers of America (PhRMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), Central Drugs Standard Control Organization (CDSCO), Indian Brand Equity Foundation (IBEF), European Medicines Agency (EMA), Global Cancer Observatory (GCO), American Chemical Society (ACS), National Center for Biotechnology Information (NCBI), Food and Drug Administration (FDA), Biotechnology and Biological Sciences Research Council (BBSRC), Pharmaceutical Research and Manufacturers of America (PhRMA), and the World Journal of Pharmaceutical Sciences, Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global proteomics market, which was then validated by primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Proteomics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Proteomics Market Size Estimation

A top-down approach was used to estimate and validate the total size of the proteomics market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the total proteomics market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the proteomics business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Proteomics Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Proteomics market size: Top-Down Approach

Proteomics Market Size, and Share

Data Triangulation

After arriving at the overall proteomics market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Proteomics is the complete evaluation of the structure and function of proteins to understand an organism’s nature. It is the systemic identification and characterization of proteins along with their sequence, abundance, post-translational modifications, interactions, activity, subcellular localization, and structure. The market study includes the assessment of various instruments, reagents, software, and services used in proteomics.

Key Stakeholders

  • Life sciences instrumentation and reagent companies
  • Pharmaceutical and biotechnology companies
  • Proteomics database and software providers
  • Proteomics service providers
  • Research and consulting firms
  • Academic medical centers
  • Government research organizations
  • Clinical research institutes
  • Contract Research Organizations

Report Objectives

  • To define, describe, and forecast the global proteomics market based on the instrumentation technologies, reagents, software & services, application, end-user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micro markets with respect to individual growth trends, future prospects, and contributions to the overall proteomics market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, collaborations, and R&D activities in the proteomics market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographic Analysis

  • Further breakdown of the Rest of Europe proteomics market into respective countries
  • Further breakdown of the Rest of Asia Pacific proteomics market into respective countries
  • Further breakdown of the Rest of Latin America proteomics market into respective countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)
  • An additional five company profiles
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2341
Published ON
Sep, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Proteomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback